Clinical Commentary
COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies

https://doi.org/10.1016/j.ygyno.2020.04.703Get rights and content

Highlights

  • •

    The pandemic COVID-19 requires alternative methods and thinking to keep healthcare professionals and patients safe.

  • •

    In COVID-19 hot spots, oral therapies may be viable alternatives to intravenous therapies for treatment of ovarian cancer.

  • •

    Minimizing patient visits to hospitals and cancer clinics may help mitigate the spread of SARS-CoV-2.

Keywords

SARS-CoV-2
COVID-19
Ovarian cancer
Oral
Targeted therapy

Cited by (0)

View Abstract
© 2020 Elsevier Inc. All rights reserved.